EOM 1352: Fri 7 June 2024, 11:36
Media Pack
News

Current Edition

Volume 17 Issue 4
Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
Regional News

Pfizer asks hourly staffers to return overpayments in aftermath of vendor’s cyberattack: reports

A little extra cash is always a welcome surprise—until your employer asks you to pay it back, that is. In December, a ransomware attack struck Ultimate Kronos Gro...
4 April 2022 Regional News cash | cyberattack
Continue Reading →
Regional News

Novo Nordisk, trying to switch patients to Rybelsus, launches new TV ad

Down with Rybelsus! No, this isn’t a line from "1984," but rather the new message from Novo Nordisk for its first Rybelsus ad of 2022. One of the biggest issues f...
4 April 2022 Regional News diabetes | FDA
Continue Reading →
Regional News

Zealand becomes a lesson in the rigors of commercialization as a slow launch triggers 90% staff cut, CEO exit

It wasn’t supposed to be this way. Zealand Pharma should be in the honeymoon glow of its first drug launch with a drug approved less than a year ago. Instead, it's lo...
4 April 2022 Regional News diabetes | FDA
Continue Reading →
Regional News

Gilead’s Kite flies higher as Yescarta leads CAR-T therapy class to earlier lymphoma treatment

Existing CAR-T therapies have been saved for blood cancer patients who’ve tried multiple treatments—until now. With a first-in-class nod, the FDA has cleared Yesc...
4 April 2022 Regional News CAR T | Gilead
Continue Reading →
Regional News

Bristol Myers CEO Caforio takes pay cut as ‘human capital’ metric drags down bonus

Bristol Myers Squibb is hoping new launches will offset a wave of forthcoming patent losses for some of its biggest-selling drugs. But in the meantime, CEO Giovanni C...
4 April 2022 Regional News Abecma | Breyanzi
Continue Reading →
Regional News

Viatris, after closing massive West Virginia plant, sells it for $1

There will be no need to take a wrecking ball to Mylan’s former manufacturing plant in Morgantown, West Virginia. The former factory, which once housed more than ...
4 April 2022 Regional News $1 | sells
Continue Reading →
Regional News

In major shake-up, Novartis combines pharma, oncology units, leaving cancer commercial head, CMO out of job

Novartis CEO Vas Narasimhan is giving the Swiss pharma a huge makeover even ahead of a possible spinoff of generics unit Sandoz, pushing out three C-level executives ...
4 April 2022 Regional News cancer | makeover
Continue Reading →
Volume 14 Issue 2

Achieving Diversity and Inclusion in COVID-19 Vaccination Trials

Moderna’s COVID-19 mRNA vaccine trial was one of the most diverse clinical trials in history. LaQuinta Jernigan, Executive Vice President for the Americas at mdgroup ...
1 April 2022 Volume 14 Issue 2
Continue Reading →
Volume 14 Issue 2

A Long but Worthwhile Wait for Vitiligo Treatments

The drug development landscape for vitiligo is sparse despite its social impact on individuals irrespective of race, ethnicity, or gender. Sometimes dubbed a “cosmeti...
1 April 2022 Volume 14 Issue 2
Continue Reading →
Volume 14 Issue 2

Accelerating the Transformation of Healthcare through Open-Source Algorithms

Wearables have the potential to transform healthcare. They can help to inform timely, data-driven interventions. But validating each new digital measure is time-consu...
1 April 2022 Volume 14 Issue 2
Continue Reading →
Catalyst: 12th January 2026
Quotient

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2026, All Rights Reserved – Powered by Teksyte